Exelixis Inc Weighted Average Number of Shares Outstanding, Basic and Diluted
Exelixis Inc (EXEL) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 250.53 million shares for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2017-02-27
- Exelixis Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-12-31 was 288.05M shares, a 26.64% increase year-over-year.
- Exelixis Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-09-30 was 256.32M shares, a 17.80% increase year-over-year.
- Exelixis Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-06-30 was 229.31M shares, a 16.88% increase year-over-year.
- Exelixis Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2016-03-31 was 228.30M shares, a 16.54% increase year-over-year.
- Exelixis Inc weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 250.53M shares, a 19.74% increase from fiscal 2015.
- Exelixis Inc weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 209.23M shares, a 7.68% increase from fiscal 2014.
- Exelixis Inc weighted average number of shares outstanding, basic and diluted for fiscal 2014 was 194.30M shares, a 5.56% increase from fiscal 2013.
- Exelixis Inc weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 184.06M shares, a 14.94% increase from fiscal 2012.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2016-12-31 | 288.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | 272.19M shares derived: average of 2 quarters · filed 2017-02-27 | 257.89M shares derived: average of 3 quarters · filed 2017-02-27 | 250.53M shares 10-K · filed 2017-02-27 |
| 2016-09-30 | 256.32M shares 10-Q · filed 2016-11-03 | 242.81M shares derived: average of 2 quarters · filed 2016-11-03 | 238.02M shares 10-Q · filed 2016-11-03 | 235.35M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2016-06-30 | 229.31M shares 10-Q · filed 2016-08-03 | 228.86M shares 10-Q · filed 2016-08-03 | 228.35M shares derived: average of 3 quarters · filed 2017-02-27 | 225.66M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2016-03-31 | 228.30M shares 10-Q · filed 2016-05-04 | 227.88M shares derived: average of 2 quarters · filed 2017-02-27 | 224.45M shares derived: average of 3 quarters · filed 2017-02-27 | 217.39M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2015-12-31 | 227.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | 222.52M shares derived: average of 2 quarters · filed 2017-02-27 | 213.75M shares derived: average of 3 quarters · filed 2017-02-27 | 209.23M shares 10-K · filed 2017-02-27 |
| 2015-09-30 | 217.59M shares 10-Q · filed 2016-11-03 | 206.89M shares derived: average of 2 quarters · filed 2016-11-03 | 203.15M shares 10-Q · filed 2016-11-03 | 201.33M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | 196.20M shares 10-Q · filed 2016-08-03 | 196.05M shares 10-Q · filed 2016-08-03 | 195.91M shares derived: average of 3 quarters · filed 2017-02-27 | 195.72M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | 195.90M shares 10-Q · filed 2016-05-04 | 195.77M shares derived: average of 2 quarters · filed 2017-02-27 | 195.55M shares derived: average of 3 quarters · filed 2017-02-27 | 195.40M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | 195.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | 195.38M shares derived: average of 2 quarters · filed 2017-02-27 | 195.23M shares derived: average of 3 quarters · filed 2017-02-27 | 194.30M shares 10-K · filed 2017-02-27 |
| 2014-09-30 | 195.13M shares 10-Q · filed 2015-11-10 | 195.03M shares derived: average of 2 quarters · filed 2015-11-10 | 193.85M shares 10-Q · filed 2015-11-10 | 191.53M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | 194.93M shares 10-Q · filed 2015-08-11 | 193.32M shares 10-Q · filed 2015-08-11 | 190.34M shares derived: average of 3 quarters · filed 2016-02-29 | 188.79M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | 191.70M shares 10-Q · filed 2015-04-30 | 188.04M shares derived: average of 2 quarters · filed 2016-02-29 | 186.74M shares derived: average of 3 quarters · filed 2016-02-29 | 186.05M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | 184.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 184.26M shares derived: average of 2 quarters · filed 2016-02-29 | 184.17M shares derived: average of 3 quarters · filed 2016-02-29 | 184.06M shares 10-K · filed 2016-02-29 |
| 2013-09-30 | 184.15M shares 10-Q · filed 2014-11-04 | 184.06M shares derived: average of 2 quarters · filed 2014-11-04 | 183.96M shares 10-Q · filed 2014-11-04 | 183.87M shares derived: average of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | 183.98M shares 10-Q · filed 2014-07-31 | 183.86M shares 10-Q · filed 2014-07-31 | 183.78M shares derived: average of 3 quarters · filed 2015-03-02 | 179.42M shares derived: average of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | 183.74M shares 10-Q · filed 2014-05-01 | 183.67M shares derived: average of 2 quarters · filed 2015-03-02 | 177.90M shares derived: average of 3 quarters · filed 2015-03-02 | 170.59M shares derived: average of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | 183.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 174.98M shares derived: average of 2 quarters · filed 2015-03-02 | 166.20M shares derived: average of 3 quarters · filed 2015-03-02 | 160.14M shares 10-K · filed 2015-03-02 |
| 2012-09-30 | 166.35M shares 10-Q · filed 2013-10-30 | 157.50M shares derived: average of 2 quarters · filed 2013-10-30 | 152.32M shares 10-Q · filed 2013-10-30 | |
| 2012-06-30 | 148.65M shares 10-Q · filed 2013-08-06 | 145.30M shares 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | 141.94M shares 10-Q · filed 2013-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |